aTyr Pharma, Inc.

Historical 13F Holders

Symbol
ATYR
CUSIP
002120202
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 002120202 since 12/18/2024, newest first.

Filer % of Class Filed
Federated Hermes, Inc. 13G/A Amendment 12
5.1% 10/7/2026
Event 9/30/2026
FMR LLC 13G/A Amendment 15
2.5% 8/6/2026
Event 6/30/2026
BlackRock, Inc. 13G/A Amendment 1 1.8% 7/27/2026
Event 6/30/2026
Federated Hermes, Inc. 13G/A Amendment 11
8.7% 7/8/2026
Event 6/30/2026
FMR LLC 13G/A Amendment 14
6.1% 6/5/2026
Event 5/29/2026
Vanguard Group Inc 13G/A Amendment 1 0% 3/26/2026
Event 3/13/2026
Federated Hermes, Inc. 13G/A Amendment 10
10.8% 10/7/2025
Event 9/30/2025
Vanguard Group Inc 13G 5.2% 7/29/2025
Event 6/30/2025
BlackRock, Inc. 13G 6.5% 7/17/2025
Event 6/30/2025
Point72 Asset Management, L.P. 13G/A Amendment 1
3.2% 5/15/2025
Event 3/31/2025
Federated Hermes, Inc. 13G/A Amendment 9
17.5% 1/8/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 1 115 $35.00
2026 Q2 100 40.6 M $24.2 M
2026 Q1 121 56.1 M $43.7 M
2025 Q4 97 54.9 M $55.8 M
2025 Q3 135 62.0 M $51.6 M
2025 Q2 123 66.5 M $337 M
2025 Q1 97 61.8 M $187 M
2024 Q4 84 54.9 M $199 M
2024 Q3 61 47.9 M $84.3 M
2024 Q2 53 51.1 M $79.8 M
2024 Q1 62 41.9 M $81.7 M
2023 Q4 53 41.4 M $58.4 M
2023 Q3 45 37.1 M $58.7 M
2023 Q2 47 35.7 M $77.0 M
2023 Q1 40 34.7 M $72.8 M
2022 Q4 41 18.4 M $40.4 M
2022 Q3 36 19.1 M $57.2 M
2022 Q2 40 18.8 M $53.1 M
2022 Q1 49 19.6 M $105 M
2021 Q4 57 20.6 M $154 M
2021 Q3 54 18.8 M $171 M
2021 Q2 30 6.79 M $33.1 M
2021 Q1 25 5.78 M $25.7 M
2020 Q4 24 5.78 M $22.4 M
2020 Q3 25 5.63 M $18.2 M
2020 Q2 25 5.47 M $24.3 M
2020 Q1 25 5.12 M $14.3 M
2019 Q4 18 1.81 M $7.53 M
2019 Q3 19 1.73 M $6.05 M
2019 Q2 6 531 k $193 k